Mer receptor tyrosine kinase is a promising novel cancer therapeutic target in many human cancers. because abnormal activation of Mer has been implicated in survival signaling and chemoresistance. 3D-QSAR analyses based on alignment independent descriptors were performed on a series of 81 Mer specific tyrosine kinase inhibitors. The fractional factorial design (FFD) and the enhanced r... https://www.spidertattooz.com/Zenith-El-Primero-36-000-VpH-03-2150-400/